|
|
Blood, 1 March 2006, Vol. 107, No. 5, pp. 2030-2036.
Prepublished online as a Blood First Edition Paper on November 29, 2005; DOI 10.1182/blood-2005-07-2696.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction
Daniela Pende,
Roberta Castriconi,
Paola Romagnani,
Grazia Maria Spaggiari,
Stefania Marcenaro,
Alessandra Dondero,
Elena Lazzeri,
Laura Lasagni,
Stefania Martini,
Paola Rivera,
Andrea Capobianco,
Lorenzo Moretta,
Alessandro Moretta, and
Cristina Bottino
From the Istituto Nazionale per la Ricerca sul Cancro, Genoa; Dipartimento di Medicina Sperimentale (DIMES), University of Genoa; Istituto Giannina Gaslini, Genoa; Center for Research, Transfer and High Education De novo therapies (DENOthe), University of Florence; Centro di Eccellenza per la Ricerca Biomedica, University of Genoa; and Dipartimento di Oncologia, Biologia e Genetica (DOBIG), University of Genoa, Italy.
In this study, we demonstrate the involvement of DNAM-1-triggering receptor and its ligands, poliovirus receptor (PVR) and Nectin-2, in natural killer (NK) cell-mediated lysis of dendritic cells (DCs). The surface expression of both ligands was up-regulated in DCs as compared to monocytes. It reached maximal densities after DC maturation induced by different stimuli including lipopolysaccharide (LPS), poly I:C, flagellin, and CD40L. Both immunohistochemical analysis and confocal microscopy revealed expression of DNAM-1 ligands by DCs in lymph nodes in which they were localized in the parafollicular T-cell region and surrounded the high endothelial venules. Remarkably, in cytolytic assays, DNAM-1 cooperated with NKp30 in the NK-mediated killing of both immature and mature DCs and the degree of contribution of DNAM-1 appeared to correlate with the surface densities of its specific ligands PVR and Nectin-2.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Carlsten, H. Norell, Y. T. Bryceson, I. Poschke, K. Schedvins, H.-G. Ljunggren, R. Kiessling, and K.-J. Malmberg
Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
J. Immunol.,
October 15, 2009;
183(8):
4921 - 4930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Seth, A.-M. Georgoudaki, B. J. Chambers, Q. Qiu, E. Kremmer, M. K. Maier, N. Czeloth, I. Ravens, R. Foerster, and G. Bernhardt
Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells
J. Leukoc. Biol.,
July 1, 2009;
86(1):
91 - 101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bozzano, P. Costa, G. Passalacqua, F. Dodi, S. Ravera, G. Pagano, G. W. Canonica, L. Moretta, and A. De Maria
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment
Int. Immunol.,
July 1, 2009;
21(7):
779 - 791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fang, X. Zhang, J. Miao, F. Zhao, K. Yang, R. Zhuang, H. Bujard, Y. Wei, A. Yang, L. Chen, et al.
Expression of CD226 Antagonizes Apoptotic Cell Death in Murine Thymocytes
J. Immunol.,
May 1, 2009;
182(9):
5453 - 5460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gilfillan, C. J. Chan, M. Cella, N. M. Haynes, A. S. Rapaport, K. S. Boles, D. M. Andrews, M. J. Smyth, and M. Colonna
DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
J. Exp. Med.,
December 22, 2008;
205(13):
2965 - 2973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lunemann, J. D. Lunemann, S. Roberts, B. Messmer, R. B. da Silva, C. S. Raine, and C. Munz
Human NK Cells Kill Resting but Not Activated Microglia via NKG2D- and NKp46-Mediated Recognition
J. Immunol.,
November 1, 2008;
181(9):
6170 - 6177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Marcenaro, B. Ferranti, M. Falco, L. Moretta, and A. Moretta
Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC
Int. Immunol.,
September 1, 2008;
20(9):
1155 - 1167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Agaugue, E. Marcenaro, B. Ferranti, L. Moretta, and A. Moretta
Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells
Blood,
September 1, 2008;
112(5):
1776 - 1783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad
Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination
J. Leukoc. Biol.,
July 1, 2008;
84(1):
27 - 49.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Lunemann and C. Munz
Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?
Brain,
July 1, 2008;
131(7):
1681 - 1683.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cerboni, A. Zingoni, M. Cippitelli, M. Piccoli, L. Frati, and A. Santoni
Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis
Blood,
July 15, 2007;
110(2):
606 - 615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Castriconi, A. Dondero, C. Cantoni, M. Della Chiesa, C. Prato, M. Nanni, M. Fiorini, L. Notarangelo, S. Parolini, L. Moretta, et al.
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency
Blood,
June 1, 2007;
109(11):
4873 - 4881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vermijlen, P. Ellis, C. Langford, A. Klein, R. Engel, K. Willimann, H. Jomaa, A. C. Hayday, and M. Eberl
Distinct Cytokine-Driven Responses of Activated Blood {gamma}{delta} T Cells: Insights into Unconventional T Cell Pleiotropy
J. Immunol.,
April 1, 2007;
178(7):
4304 - 4314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Rutjens, S. Mazza, R. Biassoni, G. Koopman, L. Radic, M. Fogli, P. Costa, M. C. Mingari, L. Moretta, J. Heeney, et al.
Differential NKp30 Inducibility in Chimpanzee NK Cells and Conserved NK Cell Phenotype and Function in Long-Term HIV-1-Infected Animals
J. Immunol.,
February 1, 2007;
178(3):
1702 - 1712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Chiesa, C. Romagnani, A. Thiel, L. Moretta, and A. Moretta
Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses
Blood,
December 1, 2006;
108(12):
3851 - 3858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mavilio, G. Lombardo, A. Kinter, M. Fogli, A. La Sala, S. Ortolano, A. Farschi, D. Follmann, R. Gregg, C. Kovacs, et al.
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection
J. Exp. Med.,
October 2, 2006;
203(10):
2339 - 2350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Bachelet, A. Munitz, D. Mankutad, and F. Levi-Schaffer
Mast Cell Costimulation by CD226/CD112 (DNAM-1/Nectin-2): A NOVEL INTERFACE IN THE ALLERGIC PROCESS
J. Biol. Chem.,
September 15, 2006;
281(37):
27190 - 27196.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|